Genesis Research Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Hoboken, NJ USA
Total Funding:N/A
Industry:Pharma
Founded:2009
Lead Investor(s):N/A

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Genesis Research's estimated annual revenue is currently $21.7M per year.(?)
  • Genesis Research's estimated revenue per employee is $201,000

Employee Data

  • Genesis Research has 108 Employees.(?)
  • Genesis Research grew their employee count by 80% last year.
  • Genesis Research currently has 1 job openings.

Genesis Research is an international healthcare consultancy specializing in end to end evidence development, optimization, and communication. The company's core competencies reside in Meta Research, Modeling, Data Analytics, Scientific Writing and Simulation & Risk Analytics. Senior Management has over 50 years of life sciences experience working in pharma, medical device, consulting, and academia. Genesis has completed over 500 client engagements since the company's inception in 2009. Through these strategic collaborations we have developed and cultivated a deep understanding of the healthcare sector and the key trends and challenges impacting the industry. Our market differentiation is in our exceptional, personalized client service. Data science requires rapid response, a deep bench of support and visually-rich and aesthetically elegant results. Our clients have come to expect results and deliverables that are tailored to their needs. Genesis also places a major emphasis on a focused and disciplined respect for timelines, efficiency and our client's budgets. Through our integrated capabilities in data analytics, epidemiology, health economics, market access and medical communications, we provide our clients with a competitive edge in this dynamic market environment. Through the expertise of our consultants, programmers, data scientists, bio-statisticians and outcomes researchers we maximize the value of data through End to End Evidence.

keywords:Biotechnology,Healthcare,Pharmaceuticals